REMS In Review: FDA's Sharfstein Sees Need For Additional Authority
This article was originally published in The Pink Sheet Daily
Executive Summary
House committee members talk Rx safety with the agency's principal deputy commissioner as they consider a path forward for a drug import safety measure.